Literature DB >> 16328568

Pituitary apoplexy and idiopathic thrombocytopenic purpura: a new case and review of the literature.

J C Maïza1, A Bennet1, M Thorn-Kany2, J Lagarrigue3, Ph Caron4,5.   

Abstract

Pituitary apoplexy can occur as a complication of idiopathic thrombocytopenic purpura. We report here a new case of such association. A male patient aged 59 years, complaining of decreased libido for one year, was referred to the emergency department for purpura and severe thrombocytopenia (4000 platelets/mm3). 24 hours after the cutaneous rash the patient presented with clinical symptoms of bilateral cavernous sinus compression comprising ptosis, bilateral ophtalmoplegia and right supraorbital hypoesthesia. Cranial CT scan showed an enlarged sella and a pituitary mass with signs of intrapituitary haemorrhage. Hormonal evaluation showed hyperprolactinemia (50 ng/mL) and hypopituitarism, and the patient needed substitution with hydrocortisone and levothyroxine. Immunoglobulins and corticosteroids were given to the patient to treat thrombocytopenia, then worsening of neurological and ophtalmological symptoms led to pituitary surgery. Histopathological examination found necrotical pituitary tissue. Immunostaining with an anti-prolactin antibody was positive in several groups of cells. Neurological symptoms subsided and thrombocytopenia was corrected by treatment. In conclusion, we report a case of pituitary apoplexy due to severe thrombocytopenia occurring as a complication of a preexisting macroprolactinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16328568     DOI: 10.1007/s11102-005-1760-6

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  16 in total

1.  HEMORRHAGE INTO PITUITARY ADENOMA DURING ANTICOAGULANT THERAPY.

Authors:  A R NOURIZADEH; F W PITTS
Journal:  JAMA       Date:  1965-08-16       Impact factor: 56.272

2.  Pituitary apoplexy as a first manifestation of pituitary adenomas following intensive thrombolytic and antithrombotic therapy.

Authors:  S Fuchs; R Beeri; Y Hasin; A T Weiss; M S Gotsman; D Zahger
Journal:  Am J Cardiol       Date:  1998-01-01       Impact factor: 2.778

3.  Pituitary apoplexy: the role of atheromatous emboli.

Authors:  E B Sussman; R S Porro
Journal:  Stroke       Date:  1974 May-Jun       Impact factor: 7.914

4.  Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma.

Authors:  P Chanson; G Schaison
Journal:  J Clin Endocrinol Metab       Date:  1995-07       Impact factor: 5.958

5.  Pregnancy-associated subacute hemorrhage into a prolactinoma resulting in diabetes insipidus.

Authors:  R Freeman; B Wezenter; M Silverstein; D Kuo; K L Weiss; A B Kantrowitz; U K Schubart
Journal:  Fertil Steril       Date:  1992-08       Impact factor: 7.329

6.  Precipitating factors in pituitary apoplexy.

Authors:  V Biousse; N J Newman; N M Oyesiku
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

7.  Pituitary apoplexy in a patient with acute myeloid leukemia and thrombocytopenia.

Authors:  N Wongpraparut; N Pleanboonlers; P Suwattee; P Rerkpattanapipat; A Turtz; M Moster; I Gala; Y N Kim
Journal:  Pituitary       Date:  2000-10       Impact factor: 4.107

8.  Pituitary apoplexy: its incidence and clinical significance.

Authors:  S Wakai; T Fukushima; A Teramoto; K Sano
Journal:  J Neurosurg       Date:  1981-08       Impact factor: 5.115

Review 9.  Pituitary apoplexy.

Authors:  C A Rolih; K P Ober
Journal:  Endocrinol Metab Clin North Am       Date:  1993-06       Impact factor: 4.741

10.  Heparin therapy for myocardial infarction: an unusual trigger for pituitary apoplexy.

Authors:  M M Oo; A Y Krishna; G J Bonavita; G W Rutecki
Journal:  Am J Med Sci       Date:  1997-11       Impact factor: 2.378

View more
  5 in total

1.  Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.

Authors:  Giovanna Aparecida Balarini Lima; Evelyn de Oliveira Machado; Cintia Marques Dos Santos Silva; Paulo Niemeyer Filho; Mônica Roberto Gadelha
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  A conservative management is preferable in milder forms of pituitary tumor apoplexy.

Authors:  C Leyer; F Castinetti; I Morange; M Gueydan; C Oliver; B Conte-Devolx; H Dufour; T Brue
Journal:  J Endocrinol Invest       Date:  2010-08-31       Impact factor: 4.256

3.  Pituitary Apoplexy Complicated by Cerebral Infarction: A Case Report.

Authors:  Biraj Pokhrel; Shambhu Khanal; Parikshit Chapagain; Gopal Sedain
Journal:  JNMA J Nepal Med Assoc       Date:  2021-07-30       Impact factor: 0.556

Review 4.  Pituitary apoplexy: considerations on a single center experience and review of the literature.

Authors:  L Giammattei; G Mantovani; G Carrabba; S Ferrero; A Di Cristofori; E Verrua; C Guastella; L Pignataro; P Rampini; M Minichiello; M Locatelli
Journal:  J Endocrinol Invest       Date:  2016-01-05       Impact factor: 4.256

5.  Pituitary metastasis presenting as ischemic pituitary apoplexy following heparin-induced thrombocytopenia.

Authors:  Ivan Kruljac; Vatroslav Cerina; Hrvoje Ivan Pećina; Leo Pažanin; Tomas Matić; Velimir Božikov; Milan Vrkljan
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.